Vicarious Surgical (RBOT) Liabilities and Shareholders Equity (2020 - 2025)

Vicarious Surgical's (RBOT) quarterly Liabilities and Shareholders Equity came in at $19.6 million in Q4 2025, down 71.08% year-on-year from $67.7 million in Q4 2024, and down 33.28% on a QoQ basis from $29.3 million in Q3 2025.

Vicarious Surgical (RBOT) Liabilities and Shareholders Equity (2020 - 2025) Analysis & Trends

Vicarious Surgical (RBOT) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $19.6 million in Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 71.08% year-over-year to $19.6 million in Q4 2025; TTM through Dec 2025 was $144.9 million, a 58.25% decrease from a year earlier, with the FY2025 full-year figure at $19.6 million, down 71.08% from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 stood at $19.6 million, down from $29.3 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for RBOT reached as high as $346.4 million in Q1 2021 and fell as low as $19.6 million in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $133.6 million across 5 years, with a median of $120.5 million in 2023.
  • Across the five-year window, Liabilities and Shareholders Equity surged 89224.63% in 2021 and tumbled 71.08% in 2025, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $181.7 million in 2021, then slipped by 22.78% to $140.3 million in 2022, then retreated by 14.56% to $119.9 million in 2023, then plunged by 43.5% to $67.7 million in 2024, then slumped by 71.08% to $19.6 million in 2025.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $19.6 million in Q4 2025, $29.3 million in Q3 2025, and $40.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Vicarious Surgical 654,984.55 -9.14 Mn - 19.58 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 19.58 Mn
Sep 30, 2025 29.35 Mn
Jun 30, 2025 40.89 Mn
Mar 31, 2025 55.05 Mn
Dec 31, 2024 67.72 Mn
Sep 30, 2024 80.62 Mn
Jun 30, 2024 93.35 Mn
Mar 31, 2024 105.29 Mn
Dec 31, 2023 119.86 Mn
Sep 30, 2023 132.05 Mn
Jun 30, 2023 104.53 Mn
Mar 31, 2023 121.09 Mn
Dec 31, 2022 140.29 Mn
Sep 30, 2022 150.68 Mn
Jun 30, 2022 164.05 Mn
Mar 31, 2022 179.97 Mn
Dec 31, 2021 181.68 Mn
Sep 30, 2021 193.36 Mn
Jun 30, 2021 345.54 Mn
Mar 31, 2021 346.35 Mn